Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 2.62B |
| Enterprise Value | 1.49B |
| P/E Ratio | -49.72 |
| PEG Ratio | -1.38 |
| Price/Sales Ratio | 1.27 |
| Price/Book Ratio | 3.52 |
| Enterprise/Revenue | -0.45 |
| Enterprise/EBITDA | 2.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.23 |
| Operating Margin | -0.26 |
| Return On Assets | -0.06 |
| Return On Equity | -0.07 |
| Revenue | 685.8M |
| Revenue/Share | 0.63 |
| Gross Profit | 616.49M |
| EBITDA | -81.53M |
| Net Income | -153.36M |
| Diluted EPS | -0.14 |
| Total Cash | 1.13B |
| Total Cash/Share | 1.09 |
| Total Debt | 13.23M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 7.46 |
| Book Value Per Share | 2.05 |
| 52-Week Change | -23.36 |
| 52-Week High | 5.29 |
| 52-Week Low | 2.2 |
| Moving Average 50 Days | 2.61 |
| Moving Average 200 Days | 3.03 |
| Average Volume | 2.07M |
| Shares Outstanding | 340M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.03 |
| Trailing Annual Dividend Yield | 0.42 |
| Payout Ratio | -0.2 |
| Last Split Factor | N/A |
| Last Split Date | N/A |